Advertisements
With Ribociclib, women with the most common type of advanced, incurable breast cancer can live longer and healthier lives by blocking an enzyme that helps to distribute tumor cells (stock image)

HEALTH ORDERS: Turning over & # 39; magic & # 39; anti-cancer drug

Advertisements

A breast cancer drug that experts & # 39; magic & # 39; is being made available to more NHS patients.

Advertisements

Ribociclib, also known as the Kisqali brand, costs £ 35,000 a year and is one of the new class of targeted therapies that focus on specific tumor characteristics rather than the & # 39; carpet bombardment & # 39; approach to chemotherapy, which also destroys healthy cells.

It has been shown that it helps when other medicines no longer work. With the daily pill, women with the most common type of advanced, incurable breast cancer can live longer and healthier by blocking an enzyme that helps share tumor cells.

With Ribociclib, women with the most common type of advanced, incurable breast cancer can live longer and healthier lives by blocking an enzyme that helps to distribute tumor cells (stock image)

With Ribociclib, women with the most common type of advanced, incurable breast cancer can live longer and healthier lives by blocking an enzyme that helps to distribute tumor cells (stock image)

In April, the National Institute for Health and Care Excellence barred doctors from offering the drug to patients who were also given an older, generally prescribed prescription for breast cancer, fulvestrant – to the anger of activists and doctors. But the watchdog has now reversed its decision, realizing that the combination of fulvestrant and ribociclib controlled the disease for another eight months, compared to fulvestrant alone.

Advertisements

Oncologist Dr. Mark Verrill, of the Freeman Hospital in Newcastle, says: & By combining these two drugs, we are about doubling the time we can control the disease, which is an important step forward. & # 39;

Could broccoli keep the secret to defeat painful osteoarthritis? That's what researchers from the University of East Anglia and Norfolk and Norwich Hospital are trying to figure out as part of a three-month trial period in which simple vegetables could become a regular treatment for the tormenting condition that 8.5 million people in the UK affects.

Researchers at the University of East Anglia and Norfolk and Norwich Hospital strive to find out whether broccoli can keep the secret to defeat painful osteoarthritis

Researchers at the University of East Anglia and Norfolk and Norwich Hospital strive to find out whether broccoli can keep the secret to defeat painful osteoarthritis

Researchers at the University of East Anglia and Norfolk and Norwich Hospital strive to find out whether broccoli can keep the secret to defeat painful osteoarthritis

The Broccoli in Osteoarthritis study follows tests on mice that showed that a substance in the sulforaphane plant slows down the destruction of cartilage in the joints.

Advertisements

Researchers are now recruiting 50 volunteers with painful joints to compare the effects of eating broccoli soup with one that looks and tastes the same, but that actually does not contain broccoli.

Patients with the most aggressive form of brain cancer should receive a radically new treatment in which tumors are irradiated with powerful radiation during surgery.

Survival rates for glioblastoma, the type that killed former minister Dame Tessa Jowell last year, are poor. The average life expectancy is only nine months.

Standard treatment includes surgery to remove the tumor and, four weeks later, radiotherapy and the chemotherapy drug temozolomide.

But those who referred to the new INTRAGO 2 study at The London Clinic, led by neurosurgeons Professor Keyoumars Ashkan and Ranj Bhangoo, will also have radiation delivered into the cavity left by the tumor while they are in the theater for all microscopic cancerous cells that are left to kill.

Survival rates for glioblastoma, the type that killed former minister Dame Tessa Jowell (photo) last year, are poor. The average life expectancy is only nine months
Advertisements

Survival rates for glioblastoma, the type that killed former minister Dame Tessa Jowell (photo) last year, are poor. The average life expectancy is only nine months

Survival rates for glioblastoma, the type that killed former minister Dame Tessa Jowell (photo) last year, are poor. The average life expectancy is only nine months

Scientists say that multiple sclerosis can someday be diagnosed by a breath test. When we exhale, we release microscopic particles and connections. Most come from the bloodstream so that they can reveal hidden physiological changes in the body, including disease activity.

Early studies have already pointed to the presence of specific respiratory connections in MS, which researchers hope to confirm and ultimately translate into a new diagnostic tool.

Dr. Susan Kohlhaas, research director at the MS Society, says: “A respiratory test may sound futuristic, but today's MS researchers are doing incredible things. These findings are very encouraging. & # 39;

Advertisements

. (TagsToTranslate) Dailymail (t) health (t) nhs